E-mail: Cedrik.Haskovec@uhkt.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
- Activation of Chromatin Structure Upstream PU.1 Gene and in Vitro Differentiation in High Risk Myelodysplastic Syndrome Following 5-Azacytidine
- CAN ESTIMATION OF WT-1 IN PERIPHERAL BLOOD HELP US IN MONITORING RESIDUAL DISEASE OF PML/RARA-POSITIVE AML PATIENTS?
- CBFβ/MYH11 Hypomethylation Signature In Patients With Acute Myeloid Leukaemia
- DIFFERENTIAL DNA METHYLATION IN AML PATIENTS WITH WILD-TYPE AND MUTATED DNMT3A AND PROGNOSTIC IMPACT OF DNA METHYLATION
- EXPRESSION LEVELS OF WT1 AND NPM1 AND NOVEL NONSPECIFIC MARKERS AS TOOLS FOR EVALUATING MINIMAL RESIDUAL DISEASE IN AML
- EXPRESSION OF WT-1 IN HUMAN ACUTE LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
- EXPRESSION OF WT-1, PRAME, RHAMM AND BAALC GENES IN PERIPHERAL BLOOD OF AML PATIENTS AT DIAGNOSIS
- MONITORING OF ABERRANTLY METHYLATED GENES IN AML PATIENTS
- MONITORING OF MRD BY NPM1 MUTATIONS FROM MRNA AND GENOMIC DNA AND ITS COMPARISON WITH EXPRESSION OF WT1 GENE IN AML PATIENTS
- MONITORING OF MRD IN PERIPHERAL BLOOD OF AML PATIENTS BY QUANTITATIVE ESTIMATION OF WT-1 LEVEL
- PHOSPHO TYROSINE KINASE PROFILLING IN PRIMARY CULTURES FROM PATIENTS WITH CHRONIC MYELOID LEUKEMIA
- RESISTANCE TO IMATINIB: WT-1 AS A POSSIBLE MARKER FOR THE EVALUATION OF UPFRONT RESISTANCE, ROLE OF KINASES OTHER THAN BCR-ABL IN SECONDARY RESISTANCE
- THREE CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIAS (CBF-AML) IN A SINGLE PATIENT
- Uplatnění genomiky (molekulární genetiky) v onkohematologii
- WHOLE GENOME AND TARGETED BISULFITE SEQUENCING REVEALS 3 DNA METHYLATION CLUSTERS AND NEW BIOLOGICALLY RELEVANT HYPERMETHYLATED GENES IN AML PATIENTS
